Among them, the biggest benefit is the biomedical industry. It is necessary to set up a M&A fund with a scale of 10 billion, which is specifically aimed at the merger and reorganization of the biomedical industry! The focus is on local enterprises in Shanghai, especially the biomedicine of listed companies in Shanghai.First, heavy! Shanghai merger and reorganization action plan announcedSay a data, since 2010, A shares have opened higher by more than 2% for 13 times, including 11 times of high opening and low walking, and only 2 times of high opening and high walking! Just get used to it, this is the urine of big A. Actually, it was good yesterday, which was in line with the slow cow. It is estimated that some people are still breathing a sigh of relief. If it rises like the beginning of October, they will not be able to sleep! You know, yesterday was a slow cow.
True Vision: The controlling shareholder and others intend to reduce their holdings by 4% in total;China Research Institute: Wang Xiuyun reduced its shareholding by 1%. At present, the company has not directly involved in the application field of humanoid robots.Many of them announced their reduction in the evening, except for the 11-board Yiming food, others also included.
Xinhua News Agency: China's monetary policy has changed from "prudent" to "moderately loose" to send a positive signal.Haineng Industry: The controlling shareholder intends to reduce the company's shares by no more than 3%;Guoxin Technology: shareholders such as the National Fund intend to reduce their holdings by no more than 3%;
Strategy guide 12-14
Strategy guide
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14